NICOTINAMIDE

Clinical trials for NICOTINAMIDE explained in plain language.

Never miss a new study

Get alerted when new NICOTINAMIDE trials appear

Sign up with your email to follow new studies for NICOTINAMIDE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a common vitamin stop liver scarring? new trial aims to find out

Disease control Recruiting now

This phase 2 trial tests whether nicotinamide (a form of vitamin B3) can stop or reverse liver fibrosis in people with non-alcoholic fatty liver disease and obesity. Thirty adults will take either nicotinamide or a placebo daily for one year. Researchers will measure liver stiffn…

Matched conditions: NICOTINAMIDE

Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

NICOTINAMIDE

Get alerted when new NICOTINAMIDE trials appear

Could a common vitamin stop liver scarring? new trial aims to find out